Global hepatitis report. 2024: action for access in low- and middle-income countries n.d.(accessed April 24, 2025). https://www.who.int/publications/i/item/9789240091672
Moradi G, Goodarzi E, Khazaei Z. Prevalence of hepatitis B and C in prisons worldwide: a meta-analysis during the years 2005–2015. Biomed Res Ther. 2018;5:2235–51. https://doi.org/10.15419/bmrat.v5i4.436.
Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, et al. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. Lancet. 2016;388:1115–26. https://doi.org/10.1016/S0140-6736(16)30769-3.
Onyemali CP, Ode DK, Madihi S. Social determinants of health (SDoH) and hepatitis B and C health inequalities among male prisoners in nigeria: A narrative Literature Review 2024. https://doi.org/10.20944/preprints202408.0910.v2
Tadesse K, Ayalew G, Million Y, Gelaw A. Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia. PLoS One. 2024;19:e0301973. https://doi.org/10.1371/journal.pone.0301973.
Busschots D, Kremer C, Bielen R, Koc ÖM, Heyens L, Nevens F, et al. Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis. BMC Public Health. 2022;22:2159. https://doi.org/10.1186/s12889-022-14623-6.
Otuu FC, Shu EN. Prevalent diseases among inmates in three federal prisons in South-East geopolitical zone of nigeria: A peep into the environmental factors. J Environ Sci Public Health. 2018;03. https://doi.org/10.26502/jesph.96120044.
Bityong RW. Detection of hepatitis C and hepatitis B virus infection among prison inmates and psychiatric patients in Kaduna Metropolis, Nigeria. Zaria: Ahmadu Bello University; 2016.
John AT, Ali M, Zakari H, Anejo-Okopi J. Prevalence and risk factors of hepatitis C virus antibodies among inmates in North central Nigeria: a cross-sectional study. UJMR. 2024;9:75–9. https://doi.org/10.47430/ujmr.2492.008.
Dan-Nwafor C, Adeoye I, Aderemi K, Adebobola B, Nguku P, Ade-Yusuf I, et al. Knowledge, serological markers and risk factors associated with hepatitis B and C virus infection among Kuje prison inmates, federal capital Territory, Nigeria. Int J Infect Dis. 2018;73:374. https://doi.org/10.1016/j.ijid.2018.04.4260.
Ajuwon BI, Yujuico I, Roper K, Richardson A, Sheel M, Lidbury BA. Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis. 2021;21(1):1120. https://doi.org/10.1186/s12879-021-06800-6.
NAIIS 2018 Collaborating Institutions. Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018 Technical Report 2018. https://ciheb.org/media/SOM/Microsites/CIHEB/documents/NAIIS-Report-2018.pdf
World Health Organization. In Nigeria, boosting viral hepatitis awareness and treatment | WHO | Regional Office for Africa 2023. https://www.afro.who.int/countries/nigeria/news/nigeria-boosting-viral-hepatitis-awareness-and-treatment-0 (accessed June 14, 2025).
Dan-Nwafor CC, Adeoye I, Aderemi K, Onuoha M, Adedire E, Bashorun A, et al. Serological markers and risk factors associated with hepatitis B virus infection among federal capital territory prison inmates, Nigeria: should we be concerned? PLoS One. 2021;16:e0248045. https://doi.org/10.1371/journal.pone.0248045.
Okafor IM, Ugwu SO, Okoroiwu HU. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterol. 2020;20:360. https://doi.org/10.1186/s12876-020-01504-8.
Lawan S, Elyuguda A, Gimba S, Sabo H, Dadile H. Hepatitis B virus infection among prison inmates in Borno state: determination of prevalence of surface antigen (HBsAg) and possible risk factors of disease. J Hepat Res. 2021;6. https://doi.org/10.26420/jhepatres.2021.1041.
Owoseni MC, Sani BE, Usman HD. Seroprevalence and risk factors of hepatitis B and C virus infection among inmates in a correctional Service, Nasarawa state. Nigeria LJSIR 2024:65–9. https://doi.org/10.62050/ljsir2024.v2n1.301
Uchechukwu OF, Abdulrahman Y, Aliyu AU, Mustaphar U, Zama I, Charles AT, et al. Seroprevalence of HIV, HBV and HCV among prisoners in Sokoto. Nigeria. AJMAH. 2018;13:1–8. https://doi.org/10.9734/AJMAH/2018/33128.
Vito-Peter B, Hart GM, Dio A, Nwogu VC, Ideozu NO, Okoro OC, et al. Seroprevalence and associated risk factors of hepatitis B and C among inmates of Port Harcourt maximum security custodial centre. AID. 2023;13:159–82. https://doi.org/10.4236/aid.2023.132016.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. https://doi.org/10.1136/bmj.n71.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4.
Joanna Briggs Institute. The Joanna Briggs Institute Critical Appraisal Tools for Use in JBI Systematic Reviews. Checklist for Analytical Cross Sectional Studies. Adelaide n.d. https://jbi.global/sites/default/files/2019-05/JBI_Critical_Appraisal-Checklist_for_Analytical_Cross_Sectional_Studies2017_0.pdf
Elijah MI. A survey for hepatitis ‘B’ infection among prison inmates in Bali prison, Taraba state. Nigeria. IOSRJPBS. 2014;9:134–7. https://doi.org/10.9790/3008-0914134137.
Ojodu A, Galadima M. Detection of hepatitis B virus from inmates in correctional facilities in Niger state. Covenant J Health Life Sci 2023;1.
Okafor IM, Okoroiwu H, Ogor CO, Esong AA. Spread of hepatitis A and B among inmates of correctional centers: a cause for concern. AJLHTS. 2023;2(4):294–306. https://doi.org/10.59708/ajlhts.v2i4.2340.
Ajakaye OG, Omidele AA. Asymptomatic plasmodium falciparum and HBV coinfections among inmates at Owo correctional facility, Nigeria. Bull Natl Res Cent. 2024;48:93. https://doi.org/10.1186/s42269-024-01253-8.
Ewaoche I, Otu-Bassey I, Nabagenyi M, Utsalo S. Prevalence and eligibility for treatment of chronic hepatitis B infection among prison inmates and female sex workers in Calabar, Cross River state. Nigeria. BMRJ. 2016;17:1–10. https://doi.org/10.9734/BMRJ/2016/27331.
Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infect Dev Ctries. 2009;3:539–47. https://doi.org/10.3855/jidc.472.
Yahaya I, Oti V. Parallel and overlapping infection of hepatitis B virus (HBV) and plasmodium falciparum among prison inmates in correctional facilities in Keffi, Nigeria. EIJ. 2020;4. https://doi.org/10.23880/EIJ-16000140.
Bhadoria AS, Gawande KB, Kedarisetty CK, Rewari BB, Pathak VK, Pandey P, et al. Prevalence of hepatitis B and C among prison inmates in india: A systematic review and Meta-Analysis. Cureus. 2021;13:e19672. https://doi.org/10.7759/cureus.19672.
Marques JMDS, Matos MA, Silva ÁMC, Freitas NR, Okita MT, Souza SDO, et al. Prevalence of overt and occult hepatitis B virus infection among an incarcerated population of Central-Western Brazil. Acta Trop. 2023;241:106886. https://doi.org/10.1016/j.actatropica.2023.106886.
Mehmandoost S, Khezri M, Mousavian G, Tavakoli F, Mehrabi F, Sharifi H, et al. Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis. Public Health. 2022;203:75–82. https://doi.org/10.1016/j.puhe.2021.11.020.
Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, et al. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health. 2013;6:186–95. https://doi.org/10.1016/j.jiph.2012.12.003.
Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18:1397–409. https://doi.org/10.1016/S1473-3099(18)30469-9.
Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388:1089–102. https://doi.org/10.1016/S0140-6736(16)30466-4.
Kowo MP, Andoulo FA, Sizimboue DT, Ndjitoyap Ndam AW, Ngek LT, Kouanfack C et al. Seroprevalence of hepatitis B and associated factors among inmates: a cross sectional study in the Douala new bell Prison, Cameroon. Pan Afr Med J 2021;38. https://doi.org/10.11604/pamj.2021.38.355.20386